UTokyo NY Conference 2018 held
November 22, 2018
The UTokyo NY Conference 2018 hosted by the University of Tokyo New York Office, Inc., and co-hosted by the Institute of Medical Science (IMS) and Institute of Industrial Science (IIS), was held at the Nippon Club Tower in New York on Saturday, November 3, 2018. Many people came from universities and research institutions in the United States, and companies and organizations in various fields to attend this conference.
The conference opened with opening remarks by Prof. Yoshinori Murakami, Dean of IMS and Dr. Yuichiro Kuwama, Vice President of the UTokyo NY Office,
followed by the introduction of each institute by Dean Murakami (IMS), and Deputy Director Katsuyuki Fukutani (IIS).
To start off the lecture portion of the conference, Project Professor Hiroshi Kiyono of IMS gave a talk under the title "Rice became a vaccine" about the development and clinical application of the next-generation oral vaccine (MucoRice) using rice. Subsequently, Professor Yuji Yamanashi of IMS gave a lecture titled "Targeting neuromuscular synapses as a new therapeutic approach for muscle weakness and atrophy." This lecture was about the development of a new gene therapy for neuromuscular diseases such as amyotrophic lateral sclerosis (ALS).
In the second part after the break, Professor Thomas Zwaka of Icahn School of Medicine at Mount Sinai gave a lecture titled "The unreasonable effectiveness of pluripotent stem cells: mechanism and mechanics" highlighting the effectiveness of pluripotent stem cells that has received much attention recently. Next, Professor Miriam Merad of Icahn School of Medicine at Mount Sinai gave a presentation titled "Harnessing the tumor microenvironment to enhance cancer care" to introduce the cutting edge data on cancer microenvironment and cancer immunotherapy. Finally, Project Professor Tadatsugu Taniguchi of IIS spoke on "The role of dead cell-derived molecules in the progression of inflammatory disease and cancer: implications for the development of new therapeutic approaches.” His talk focused on the development of new treatments for inflammatory diseases and cancers.
The attendees showed great interest in each lecture, and so many lively exchanges were held that they ran out of time during the question and answer session.
Finally, this successful conference was concluded with closing remarks by the Deputy Director of IIS, Prof. Fukutani.
Many attendees also participated in the reception following the conference, and exchanges were fostered that cross not only research discipline boundaries, but national boundaries as well. Amid such meaningful exchanges, further utilization of the New York Office is expected in the future.
Group photo of speakers and organizers
Lecture by Project Prof. Hiroshi Kiyono of IMS
Lecture by Prof. Yuji Yamanashi of IMS
Lecture by Prof. Thomas Zwaka (Icahn School of Medicine at Mount Sinai)
Lecture by Prof. Miriam Merad (Icahn School of Medicine at Mount Sinai)
Lecture by Project Prof. Tadatsugu Taniguchi of IIS
The conference opened with opening remarks by Prof. Yoshinori Murakami, Dean of IMS and Dr. Yuichiro Kuwama, Vice President of the UTokyo NY Office,
followed by the introduction of each institute by Dean Murakami (IMS), and Deputy Director Katsuyuki Fukutani (IIS).
To start off the lecture portion of the conference, Project Professor Hiroshi Kiyono of IMS gave a talk under the title "Rice became a vaccine" about the development and clinical application of the next-generation oral vaccine (MucoRice) using rice. Subsequently, Professor Yuji Yamanashi of IMS gave a lecture titled "Targeting neuromuscular synapses as a new therapeutic approach for muscle weakness and atrophy." This lecture was about the development of a new gene therapy for neuromuscular diseases such as amyotrophic lateral sclerosis (ALS).
In the second part after the break, Professor Thomas Zwaka of Icahn School of Medicine at Mount Sinai gave a lecture titled "The unreasonable effectiveness of pluripotent stem cells: mechanism and mechanics" highlighting the effectiveness of pluripotent stem cells that has received much attention recently. Next, Professor Miriam Merad of Icahn School of Medicine at Mount Sinai gave a presentation titled "Harnessing the tumor microenvironment to enhance cancer care" to introduce the cutting edge data on cancer microenvironment and cancer immunotherapy. Finally, Project Professor Tadatsugu Taniguchi of IIS spoke on "The role of dead cell-derived molecules in the progression of inflammatory disease and cancer: implications for the development of new therapeutic approaches.” His talk focused on the development of new treatments for inflammatory diseases and cancers.
The attendees showed great interest in each lecture, and so many lively exchanges were held that they ran out of time during the question and answer session.
Finally, this successful conference was concluded with closing remarks by the Deputy Director of IIS, Prof. Fukutani.
Many attendees also participated in the reception following the conference, and exchanges were fostered that cross not only research discipline boundaries, but national boundaries as well. Amid such meaningful exchanges, further utilization of the New York Office is expected in the future.
Group photo of speakers and organizers
Lecture by Project Prof. Hiroshi Kiyono of IMS
Lecture by Prof. Yuji Yamanashi of IMS
Lecture by Prof. Thomas Zwaka (Icahn School of Medicine at Mount Sinai)
Lecture by Prof. Miriam Merad (Icahn School of Medicine at Mount Sinai)
Lecture by Project Prof. Tadatsugu Taniguchi of IIS
